Summary
DexCom, Inc. (DXCM) filed an 8-K on January 10, 2007, to report preliminary, unaudited revenue estimates for the fourth quarter of 2006. The company anticipates approximately $835,000 in revenue, driven by sales of 840 starter kits. This represents a sequential increase in sensor revenues of approximately 15% compared to the third quarter of 2006, indicating positive top-line growth. During the JP Morgan 25th Annual Healthcare Conference, the CEO also provided an update on manufacturing and product performance. While no future financial guidance is expected, the reported revenue figures and sequential growth suggest early traction for DexCom's products. Investors should note that these are unaudited figures and are being furnished, not filed, under Section 2.02 of Form 8-K.
Key Highlights
- 1Unaudited Q4 2006 revenue estimated at approximately $835,000.
- 2Approximately 840 starter kits sold in Q4 2006.
- 3Sensor revenues showed a sequential increase of approximately 15% in Q4 2006 compared to Q3 2006.
- 4CEO provided an update on manufacturing and product performance.
- 5No future financial guidance is being provided by the company.
- 6Information is furnished under Item 2.02 of Form 8-K and is not considered 'filed'.
- 7The report details remarks made at the JP Morgan 25th Annual Healthcare Conference.